Cronos Australia
Cronos Australia is committed to providing Australian patients access to the highest quality medicinal cannabis products, as well as supplying export markets globally. Our vision is to become a leading health and wellness company in the Asia Pacific region with a portfolio of cannabinoid products – including THC and CBD.
Our business model is underpinned by innovative product and brand development, outsourced manufacturing and distribution for Australia and target export markets.
Three Pillars
Cronos Australia’s operations are based on Pillars;
Our medicinal cannabis products including premium quality, value priced, GMP certified medicinal cannabis oils.
Our Cannadoc Medicinal Cannabis Clinic business located in Melbourne, Australia and Wellington, New Zealand. The clinics conduct patient consultations face-to-face and nationwide via telehealth.
Our Asia consumer business, with the in-market BATHING SHED brand with two additional consumer brands being launched in 2021 for the lucrative North Asia markets including Hong Kong and Japan.
CBD Joint Venture – An innovative joint venture with the Founders of Sukin Natural Skincare for the Australian over-the-counter CBD market and target export markets.
Cronos Australia is listed on the ASX, under the code CAU.
LEADERSHIP - Board
Director
Shane F. Tanner
Qualifications: Dip Bus (RMIT), Grad Dip Bus (Swinburne), FCPA, ACIS, MAICD
Other responsibilities: Member of Audit and Risk Committee, Member of Nomination and Remuneration Committee
Other Directorships: Paragon Care Limited (ASX: PGC) (Chairman)
Shane Tanner was appointed Independent Non-Executive Chairman of Cronos Australia on 9 October 2018. Formerly, Shane was Chairman of Vision Eye Institute (ASX: VEI), Chief Executive Officer of Mayne Nickless Diagnostic Services (later renamed Symbion Health (ASX: SYB)) and Chief Financial Officer of Mayne Group. Shane has significant strategy and transaction experience, including whilst working at Mayne Group via the IPO of telecommunications company, Optus Communications.
Director
Rodney D. Cocks CSM
Qualifications: BCom (Melb.), LLB (QUT), MBA (Wharton), MPA (Harvard), GAICD
Rodney Cocks CSM was appointed Executive Director and Chief Executive Officer of Cronos Australia on 27 September 2018. He is a Director of NewSouthern Capital Pty. Ltd., a private equity firm he co-founded. Prior to joining CAL, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army. Rodney holds a BCom from the University of Melbourne, LLB from the Queensland University of Technology, MBA from the Wharton School, University of Pennsylvania, MPA from the Harvard Kennedy School, Harvard University and is a Graduate of the Australian Institute of Company Directors and the Royal Military College, Duntroon. He is an admitted Lawyer to the Supreme Court of New South Wales, was a Fellow at Harvard University and named the 2005 Victorian Australian of the Year. In 2003, Rodney was awarded a Conspicuous Service Medal for his actions in the aftermath of the 2002 Bali bombings.
Director
Daniel E. Abrahams
Qualifications: BBus (Accounting and Finance) (Central Queensland Uni.), FCPA, FCIS
Other responsibilities: Chairman of Audit and Risk Committee, Member of Nomination and Remuneration Committee
Daniel Abrahams was appointed as an Independent Non-Executive Director of Cronos Australia on 17 October 2018. Daniel is an independent consultant providing practical expertise on entrepreneurship and leadership programs to universities, helping students and alumni take ideas to commercialisation, and acting as an independent adviser to companies on scaling up. Prior to this, Daniel was an Executive Director and Chief Executive Officer of Superloop Limited (ASX: SLC), taking the company to IPO and overseeing its infrastructure rollout in Australia, Singapore and Hong Kong. Daniel has also held senior executive positions at Aurizon Holdings Limited (ASX: AZJ), Suncorp Group Limited (ASX: SUN), Energex and Toyota Tsusho South Pacific.
Director
Jason M. Adler
Qualifications: BA (University of Rhode Island)
Other Directorships: Cronos Group Inc. (NASDAQ: CRON; TSX: CRON)
Michael Gorenstein was appointed as a Non-Executive Director of CAL on 1 April 2019. Michael is the Executive Chairman of Cronos Group Inc., the Company’s largest shareholder. He also serves as the Chairman of Cronos Group’s Board. He is a co-founder and passive Member of Gotham Green Partners and sits on the Board of Directors of Natuera, Cronos Group’s South American joint venture. Before joining Cronos Group, Michael was the Vice President and General Counsel at Alphabet Partners, LP, a New York City based multi-strategy investment management firm, focused on identifying mispriced assets across various industries, asset classes and geographies. Prior to Alphabet Partners, LP, he was a corporate attorney at Sullivan & Cromwell LLP where he focused on mergers and acquisitions and capital markets transactions. Michael graduated from the University of Pennsylvania Law School with a Juris Doctor, the Wharton School at University of Pennsylvania with a certificate in Business Economics and Public Policy and the Kelley School of Business at
Indiana University with a Bachelor of Science Business in Finance.
Director
Anna E. Burke AO
Qualifications: BA (Hons), MCom (Hons) (University of Melbourne), GAICD
Other responsibilities: Member of Audit and Risk Committee, Chairman of Nomination and Remuneration Committee
Anna Burke AO was appointed as an Independent Non-Executive Director of Cronos Australia on 8 October 2018. Anna served in the Australian Federal Parliament as the Member for Chisholm in the House of Representatives from 1998 to 2016, and was also the 28th Speaker of the Australian House of Representatives. She currently serves as a Member of the Administrative Appeals Tribunal. Anna had extensive Committee service in the Federal Parliament, including serving as a member of the Joint Statutory Committee on Corporations and Financial Services and the House of Representatives Standing Committee on Economic, Finance and Public Administration. Prior to Anna’s parliamentary career, she was an Industrial Officer with VicRoads, Victorian University of Technology and the Financial Sector Union. Anna was appointed as an Officer of the Order of Australia in January 2019 for distinguished service to the Parliament of Australia, particularly as Speaker of the House of Representatives, and to the community.
Director
Michael R. Gorenstein
Qualifications: JD (University of Pennsylvania), BEPP (Wharton), BBS (Finance) (Kelley)
Other Directorships: Cronos Group Inc. (NASDAQ: CRON; TSX: CRON)
Michael Gorenstein was appointed as a Non-Executive Director of CAL on 1 April 2019. Michael is the Executive Chairman of Cronos Group Inc., the Company’s largest shareholder. He also serves as the Chairman of Cronos Group’s Board. He is a co-founder and passive Member of Gotham Green Partners and sits on the Board of Directors of Natuera, Cronos Group’s South American joint venture. Before joining Cronos Group, Michael was the Vice President and General Counsel at Alphabet Partners, LP, a New York City based multi-strategy investment management firm, focused on identifying mispriced assets across various industries, asset classes and geographies. Prior to Alphabet Partners, LP, he was a corporate attorney at Sullivan & Cromwell LLP where he focused on mergers and acquisitions and capital markets transactions. Michael graduated from the University of Pennsylvania Law School with a Juris Doctor, the Wharton School at University of Pennsylvania with a certificate in Business Economics and Public Policy and the Kelley School of Business at Indiana University with a Bachelor of Science Business in Finance.
Management
Rodney D. Cocks CSM
Qualifications: BCom (Melb.), LLB (QUT), MBA (Wharton), MPA (Harvard), GAICD
Rodney Cocks CSM was appointed Executive Director and Chief Executive Officer of Cronos Australia on 27 September 2018. He is a Director of NewSouthern Capital Pty. Ltd., a private equity firm he co-founded. Prior to joining CAL, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army. Rodney holds a BCom from the University of Melbourne, LLB from the Queensland University of Technology, MBA from the Wharton School, University of Pennsylvania, MPA from the Harvard Kennedy School, Harvard University and is a Graduate of the Australian Institute of Company Directors and the Royal Military College, Duntroon. He is an admitted Lawyer to the Supreme Court of New South Wales, was a Fellow at Harvard University and named the 2005 Victorian Australian of the Year. In 2003, Rodney was awarded a Conspicuous Service Medal for his actions in the aftermath of the 2002 Bali bombings.
Management
Thomas G. Howitt
Qualifications: BCom (University of Western Australia), CA, AICPA, AGIA, ACIS, CTA
Thomas Howitt was appointed as the Chief Financial Officer of CAL on 3 December 2018 and as Company Secretary on 14 August 2020. Prior to joining the Company, he was the Chief Financial Officer of Global Kinetics Corporation, a pre-IPO life sciences company, Chief Financial Officer/ Company Secretary of Simavita (ASX:SVA, TSX-V:SV) a digital healthcare company, Chief Financial Officer/Company Secretary of Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE) a genetic testing company, and several other listed life science companies. Prior to that, Thomas worked in the investment banking industry and was a Taxation Manager at EY. Thomas is a member of the Victorian Branch Committee of AusBiotech and a member of the CCRM Australia Industry Interface Committee based at Monash University
Management
Tyson E. Craig
Qualifications: Bcom (Curtin University), MBA (Melbourne Business School)
Tyson Craig joined Cronos Australia on 1 July 2018 and was appointed as General Manager of Operations on 1st of January 2021, with responsibility across all the business units. Previously, Tyson was a Project Manager with Linfox, with a focus on logistics, property developments, renewable energy and sustainability. In this role, Tyson oversaw the feasibility analysis, business development, procurement, design and construct tenders
and commissioning of multiple distribution centres across Australia. He is a Bachelor of Commerce graduate of Curtin University and holds a Master of Business Administration from The Melbourne Business School. In his current role, Tyson has managed the development of the Adaya medicinal cannabis range with the objective to provide medical practitioners and support patients with the highest quality, most affordable, sustainable and accessible products in Australia.
Management
Nicholas G. Mulcahy
Qualifications: MA LLB (Hons.)
Prior to joining Cronos Australia in 2019, Nick Mulcahy advised leading direct-to-consumer brands and private equity firms. He lives in Hong Kong and started his career at law firms in Sydney, working in London and across Asia. From 2006 to 2014, he was the head of Asia Pacific at Aesop, building it into a highly respected and coveted brand across Japan, Korea, Hong Kong, Taiwan, Singapore, Malaysia and Australia. Nick holds degrees in Arts and Law from the University of Sydney and a postgraduate degree in Arts from the University of New South Wales. He studied competitive strategy at Harvard Business School.
Management
Dr. Jian Hui (David) Feng
Qualifications: MBChB, BSc, FRACGP
Dr. David Feng is a founding member and the Medical Director of Cannadoc Health Pty. Ltd., a Melbourne-based medical clinic business specialising in the delivery of cannabinoid therapies, in which Cronos Australia holds a 51% equity interest. A graduate of the University of Otago, New Zealand (Bachelor of Medicine and Bachelor of Surgery), David completed his specialist GP training in Melbourne, and became a fellow of the Royal Australian College of General Practitioners in 2016. He has a special interest in medicinal cannabis and is passionate about educating patients and medical practitioners in cannabinoid therapies.